21 – 40 of 69
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
(
- Contribution to journal › Article
-
Mark
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
(
- Contribution to journal › Article
-
Mark
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
(
- Contribution to journal › Article
-
Mark
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index.
(
- Contribution to journal › Article
- 2011
-
Mark
Tumor markers in prostate cancer I: Blood-based markers
(
- Contribution to journal › Scientific review
-
Mark
A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
(
- Contribution to journal › Article
-
Mark
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
(
- Contribution to journal › Article
-
Mark
Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.
(
- Contribution to journal › Article
- 2010
-
Mark
miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions.
(
- Contribution to journal › Article
-
Mark
Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
(
- Contribution to journal › Article
-
Mark
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer : Case-control study
(
- Contribution to journal › Article
- 2009
-
Mark
THE P-MARK BIOBANK: A EUROPEAN MULTICENTER BIOREPOSITORY FOR PROSTATE CANCER RESEARCH
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.165-165(
- Contribution to journal › Published meeting abstract
-
Mark
Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
(
- Contribution to journal › Article
- 2008
-
Mark
ENSAM: Europium Nanoparticles for Signal Enhancement of Antibody Microarrays on Nanoporous Silicon.
(
- Contribution to journal › Article
-
Mark
The role of SPINK1 in ETS rearrangement-negative prostate cancers
(
- Contribution to journal › Article
-
Mark
Long-term prediction of prostate cancer: Prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study
(
- Contribution to journal › Article
-
Mark
Alteration of prostate specific antigen (PSA) in blood linked to cancer
2008) Swedish Proteomics Society Symposium, 2008(
- Contribution to conference › Abstract
- 2007
-
Mark
The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically-based screening strategy
(
- Contribution to journal › Article